JAZZ - Jazz Pharmaceuticals PLC (JAZZ) CEO Bruce Cozadd on Q3 2021 Results - Earnings Call Transcript
Jazz Pharmaceuticals PLC (JAZZ) Q3 2021 Earnings Conference Call November 09, 2021, 16:30 ET Company Participants Andrea Flynn - VP & Head, IR Bruce Cozadd - Co-Founder, Chairman & CEO Daniel Swisher - President Robert Iannone - EVP, Research & Development & Chief Medical Officer Renee Gala - EVP & CFO Kim Sablich - EVP & GM, North America Conference Call Participants Marc Goodman - SVB Leerink Jason Gerberry - Bank of America Merrill Lynch Jessica Fye - JPMorgan Chase & Co. Jeff Hung - Morgan Stanley Ami Fadia - Needham & Company Gary Nachman - BMO Capital Markets Akash Tewari - Jefferies Balaji Prasad - Barclays Bank Esther Rajavelu - UBS Aaron Gal - Sanford C. Bernstein & Co. Brandon Folkes - Cantor Fitzgerald & Co. David Amsellem - Piper Sandler & Co. Kenneth Cacciatore - Cowen and Company Gregory Fraser - Truist Securities Navann Ty - Citigroup Presentation
For further details see:
Jazz Pharmaceuticals PLC (JAZZ) CEO Bruce Cozadd on Q3 2021 Results - Earnings Call Transcript